Stock Research: Bachem

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Bachem

SWX:BANB CH0012530207
85
  • Value
    74
  • Growth
    41
  • Safety
    Safety
    94
  • Combined
    94
  • Sentiment
    46
  • 360° View
    360° View
    85
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Bachem Holding AG is a biochemical company providing services to the pharmaceutical and biotechnology industries. It focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs). It operates under the Bachem and Clinalfa brands. The company operates in Switzerland and the United States. In the last fiscal year, the company had a market cap of $5,320 million, profits of $201 million, and revenue of $667 million, with 2207 employees.

more
Index
SDG 12
SDG 3
SDG 4
SDG 8
SPI
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
74 47 45 35
Growth
41 24 83 99
Safety
Safety
94 100 98 90
Sentiment
46 75 13 12
360° View
360° View
85 85 82 73
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
11 5 1 17
Opinions Change
78 62 75 26
Pro Holdings
n/a 80 53 72
Market Pulse
45 87 4 38
Sentiment
46 75 13 12
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
74 47 45 35
Growth
41 24 83 99
Safety Safety
94 100 98 90
Combined
94 78 100 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
47 33 30 11
Price vs. Earnings (P/E)
28 13 17 28
Price vs. Book (P/B)
59 40 37 13
Dividend Yield
67 72 63 61
Value
74 47 45 35
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
94 75 80 75
Profit Growth
25 42 56 78
Capital Growth
44 11 95 86
Stock Returns
23 37 35 95
Growth
41 24 83 99
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
94 95 96 49
Refinancing
55 60 59 96
Liquidity
98 100 100 96
Safety Safety
94 100 98 90

Similar Stocks

Discover high‑ranked alternatives to Bachem and broaden your portfolio horizons.

SoftwareONE Holding

SWX:SWON
Country: Switzerland
Industry: Technology Distributors
Size: Medium
Full Stock Analysis

ALSO

SWX:ALSN
Country: Switzerland
Industry: Technology Distributors
Size: Medium
Full Stock Analysis

Krka

LJSE:KRKG
Country: Slovenia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: